Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Fallon

Showing results (71-80 of 113) with videos related to

Pageof 12
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 7, 2013
Utility of Oatp1a/1b-knockout and OATP1B1/3-humanized mice in the study of OATP-mediated pharmacokinetics and tissue distribution: case studies with pravastatin, atorvastatin, simvastatin, and carboxydichlorofluoresceinJ William Higgins, Jing Q Bao, Alice B Ke, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 4, 2022
Activity and Expression of Carboxylesterases and Arylacetamide Deacetylase in Human Ocular TissuesAnam Hammid, John K Fallon, Toni Lassila, et al.
Alimentary Pharmacology & Therapeutics|January 13, 2015
Infliximab reverses inflammatory muscle wasting (sarcopenia) in Crohn's diseaseK Subramaniam, K Fallon, T Ruut, et al.
Frontiers in Pharmacology|January 28, 2026
Development of an <i>in vitro</i> metabolic dysfunction-associated steatohepatitis model to investigate altered drug metabolizing enzymes, transport proteins, and hepatobiliary dispositionWilliam A Murphy, Sarina Kyburz, Henry Ho, et al.
Nanomedicine (London, England)|July 9, 2014
Theranostic nanoemulsions: codelivery of hydrophobic drug and hydrophilic imaging probe for cancer therapy and imagingXinggang Yang, Dun Wang, Yan Ma, et al.
Cellular and Molecular Life Sciences : CMLS|December 30, 2025
Evaluation of a human 3D multicellular hepatic spheroid model as a platform for studying hepatic transportersMattie Hartauer, Henry Ho, Meimei Wan, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 12, 2023
Aldehyde oxidase 1 activity and protein expression in human, rabbit, and pig ocular tissuesAnam Hammid, John K Fallon, Kati-Sisko Vellonen, et al.
Journal of Biological Engineering|May 8, 2019
Molecular transport through primary human small intestinal monolayers by culture on a collagen scaffold with a gradient of chemical cross-linkingJennifer E Speer, Dulan B Gunasekara, Yuli Wang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 4, 2017
Quantitative Characterization of Major Hepatic UDP-Glucuronosyltransferase Enzymes in Human Liver Microsomes: Comparison of Two Proteomic Methods and Correlation with Catalytic ActivityBrahim Achour, Alyssa Dantonio, Mark Niosi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 4, 2025
N-acetyltransferase (NAT) 1 and NAT2 enzyme activities drive interindividual variability in sulfamethoxazole N-acetylationRaeanne M Lanphier, Bethany D Latham, Amanda J Gerringer, et al.
Pageof 12

Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 7, 2013
Utility of Oatp1a/1b-knockout and OATP1B1/3-humanized mice in the study of OATP-mediated pharmacokinetics and tissue distribution: case studies with pravastatin, atorvastatin, simvastatin, and carboxydichlorofluoresceinJ William Higgins, Jing Q Bao, Alice B Ke, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 4, 2022
Activity and Expression of Carboxylesterases and Arylacetamide Deacetylase in Human Ocular TissuesAnam Hammid, John K Fallon, Toni Lassila, et al.
Alimentary Pharmacology & Therapeutics|January 13, 2015
Infliximab reverses inflammatory muscle wasting (sarcopenia) in Crohn's diseaseK Subramaniam, K Fallon, T Ruut, et al.
Frontiers in Pharmacology|January 28, 2026
Development of an <i>in vitro</i> metabolic dysfunction-associated steatohepatitis model to investigate altered drug metabolizing enzymes, transport proteins, and hepatobiliary dispositionWilliam A Murphy, Sarina Kyburz, Henry Ho, et al.
Nanomedicine (London, England)|July 9, 2014
Theranostic nanoemulsions: codelivery of hydrophobic drug and hydrophilic imaging probe for cancer therapy and imagingXinggang Yang, Dun Wang, Yan Ma, et al.
Cellular and Molecular Life Sciences : CMLS|December 30, 2025
Evaluation of a human 3D multicellular hepatic spheroid model as a platform for studying hepatic transportersMattie Hartauer, Henry Ho, Meimei Wan, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 12, 2023
Aldehyde oxidase 1 activity and protein expression in human, rabbit, and pig ocular tissuesAnam Hammid, John K Fallon, Kati-Sisko Vellonen, et al.
Journal of Biological Engineering|May 8, 2019
Molecular transport through primary human small intestinal monolayers by culture on a collagen scaffold with a gradient of chemical cross-linkingJennifer E Speer, Dulan B Gunasekara, Yuli Wang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 4, 2017
Quantitative Characterization of Major Hepatic UDP-Glucuronosyltransferase Enzymes in Human Liver Microsomes: Comparison of Two Proteomic Methods and Correlation with Catalytic ActivityBrahim Achour, Alyssa Dantonio, Mark Niosi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 4, 2025
N-acetyltransferase (NAT) 1 and NAT2 enzyme activities drive interindividual variability in sulfamethoxazole N-acetylationRaeanne M Lanphier, Bethany D Latham, Amanda J Gerringer, et al.
Pageof 12